Market Tracker

10/20 5:16pm ET

Abiomed Inc (NASDAQ:ABMD)

174.62
Delayed Data
As of Oct 20
 +2.41 / +1.40%
Today’s Change
95.14
Today|||52-Week Range
175.79
+54.97%
Year-to-Date

Today’s Trading

Previous close172.21
Today’s open173.40
Day’s range172.27 - 175.79
Volume209,566
Average volume (3 months)288,753
Market cap$7.7B
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+85.64%
Earnings growth (next 5 years)+40.50%
Revenue growth (last year)+35.13%
P/E ratio102.7
Price/Sales12.56
Price/Book16.87

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc-0.20-0.44%
WSTWest Pharmaceutical ...+1.56+1.69%
MASIMasimo Corp+0.79+0.92%
IARTIntegra LifeSciences...+0.56+1.10%
Data as of 4:02pm ET, 10/20/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)$0.38
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts